We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HYPE3 market cap is 18.08B. The company's latest EPS is BRL and P/E is N/A.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Revenue | 2.39B | 2.58B | 2.03B | 2.65B | 2.58B |
Operating Income | 678.15M | 682.95M | 535.8M | 734.13M | 735.84M |
Net Income | 465.37M | 427.88M | 338.44M | 503.04M | 499.43M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Revenue | 4.12B | 4.98B | 7.08B | 8.97B | 9.56B |
Operating Income | 1.05B | 1.28B | 1.53B | 2.47B | 2.52B |
Net Income | 1.16B | 1.3B | 1.33B | 1.7B | 1.65B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 22.55B | 23.76B | 22.52B | 23.81B | 24.27B |
Total Liabilities | 12.05B | 13.1B | 11.7B | 12.75B | 12.87B |
Total Equity | 10.5B | 10.66B | 10.82B | 11.06B | 11.4B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 11.92B | 17.25B | 19.82B | 23.76B | 24.51B |
Total Liabilities | 3.21B | 8.01B | 9.98B | 13.1B | 12.99B |
Total Equity | 8.71B | 9.24B | 9.83B | 10.66B | 11.52B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Operating | 1.52B | 2.04B | 301.52M | 879.6M | 1.6B |
Investing | -1.51B | -1.74B | -170.62M | -373.95M | -611.49M |
Financing | -86.53M | 278.96M | -1.91B | -1.23B | -1.64B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Operating | 823.88M | 1.18B | 1.4B | 2.04B | 2.4B |
Investing | -306.53M | -1.9B | -4.41B | -1.74B | -791.19M |
Financing | 82.21M | 3.21B | 557.06M | 278.96M | -1.89B |
Market Cap | 18.08B |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 633.42M |
Average Volume (1 week) | 4.01M |
Average Volume (1 Month) | 3.67M |
52 Week Change | -20.25% |
52 Week High | 46.84 |
52 Week Low | 27.11 |
Spread (Intraday) | 0.83 (2.87%) |
Company Name | Hypera Pharma |
Address |
rua nova cidade, 404 bairro, vila olimpia sao paulo, sao paulo 04547 070 |
Website | https://www.hypermarcas.com.br |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions